XML 23 R17.htm IDEA: XBRL DOCUMENT v3.25.3
Equity based Compensation
9 Months Ended
Sep. 30, 2025
Share-Based Payment Arrangement [Abstract]  
Equity-based Compensation

(9) Equity-based Compensation

On January 1, 2025, the number of shares of common stock available for issuance under the 2015 Equity Incentive Award Plan (the 2015 Plan) and the 2015 Employee Stock Purchase Plan (ESPP) was increased by 584,805 shares and 116,961 shares, respectively, due to the annual evergreen provision to increase shares available under the 2015 Plan and the ESPP. As of September 30, 2025, there were an aggregate of 1,384,632 shares available for future grant under the 2017 Stock Incentive Plan (the 2017 Plan) and the 2015 Plan, and 303,956 shares available for future grant under the ESPP.

The following table summarizes equity‑based compensation expense within the Company’s interim unaudited consolidated statements of operations and comprehensive loss for the three and nine months ended September 30, 2025 and 2024 (in thousands):

 

 

 

Three Months Ended September 30,

 

 

 

Nine Months Ended September 30,

 

 

 

2025

 

 

2024

 

 

 

2025

 

 

2024

 

Research and development

 

$

 

 

$

 

 

 

$

 

 

$

232

 

General and administrative

 

 

33

 

 

 

102

 

 

 

 

87

 

 

 

466

 

Restructuring charges: expense acceleration

 

 

 

 

 

 

 

 

 

 

 

 

2,123

 

 

 

$

33

 

 

$

102

 

 

 

$

87

 

 

$

2,821

 

 

The following table summarizes equity‑based compensation expense by type of award for the three and nine months ended September 30, 2025 and 2024 (in thousands):

 

 

 

Three Months Ended September 30,

 

 

 

Nine Months Ended September 30,

 

 

 

2025

 

 

2024

 

 

 

2025

 

 

2024

 

Stock options

 

$

9

 

 

$

69

 

 

 

$

32

 

 

$

1,851

 

Restricted stock awards

 

 

24

 

 

 

33

 

 

 

 

55

 

 

 

992

 

ESPP

 

 

 

 

 

 

 

 

 

 

 

 

(22

)

 

 

$

33

 

 

$

102

 

 

 

$

87

 

 

$

2,821

 

During the nine months ended September 30, 2025, the Company did not grant any stock options. As of September 30, 2025, there was $0.03 million of unrecognized share-based compensation related to unvested stock option grants which is expected to be recognized over a weighted average period of 1.06 years. The total unrecognized share-based compensation cost will be adjusted for actual forfeitures as they occur.

During the nine months ended September 30, 2025, the Company granted 30,000 restricted stock awards with a weighted average grant date fair value of $1.12. As of September 30, 2025, there was approximately $0.03 million of unrecognized share-based compensation related to restricted stock awards granted, which is expected to be recognized over a weighted average period of 0.4 years. The total unrecognized share-based compensation cost will be adjusted for actual forfeitures as they occur.

For a full description of the Company’s equity plans, refer to Note 10, Equity-based Compensation and Equity Incentive Plans in the audited financial statements included in the 2024 Annual Report.